ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2026)

ProQR Therapeutics has reported Other Operating Expenses for 9 years, with the latest figure at -$0.0 in Q1 2025.

• Quarterly Other Operating Expenses changed N/A year-over-year to -$0.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$0.0 (up 88.89% YoY) and the FY2022 annual result came in at -$0.0, changed N/A from the prior year.
• Other Operating Expenses improved to -$0.0 in Q1 2025 per PRQR's latest filing, from -$0.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $0.0 in Q4 2023 and troughed at -$0.0 in Q4 2024.
• A 5-year average of -$0.0 and a median of -$0.0 in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2024: Other Operating Expenses plunged 300.0% in 2022, then plunged 200.0% in 2024.
• Over 5 years, Other Operating Expenses stood at $0.0 in 2021, then surged by 100.0% to $0.0 in 2022, then jumped by 300.0% to $0.0 in 2023, then slumped by 200.0% to -$0.0 in 2024, then surged by 87.5% to -$0.0 in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.